EUR 14,07
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New.
Condizione: New.
EUR 13,00
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2011
ISBN 10: 3844387536 ISBN 13: 9783844387537
Da: preigu, Osnabrück, Germania
EUR 43,30
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. The cure of drug-resistant tuberculosis | An Insight | Sheetal Arora | Taschenbuch | 68 S. | Englisch | 2011 | LAP LAMBERT Academic Publishing | EAN 9783844387537 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu.
EUR 105,95
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 68 pages. 8.43x5.75x0.24 inches. In Stock.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing Aug 2011, 2011
ISBN 10: 3844387536 ISBN 13: 9783844387537
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 49,00
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The emergence of multidrug-resistant strains of Mycobacterium tuberculosis (Mtb) has intensified efforts to discover novel drugs for tuberculosis (TB) treatment. Targeting the persistent state of Mtb, a condition in which Mtb is resistant to conventional drug therapies, is of particular interest. Persistent bacterial population relies on metabolic pathways that become active in low nutrient environment like glyoxylate shunt. Since the glyoxylate shunt enzymes are not present in mammals, they make attractive drug targets. This study is focused on malate synthase (MS), one of the enzymes in the glyoxylate shunt. 68 pp. Englisch.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2011
ISBN 10: 3844387536 ISBN 13: 9783844387537
Da: moluna, Greven, Germania
EUR 41,05
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Arora SheetalSheetal Arora, Studied M.Tech Biotechnology at NIT Rourkela India. Working as Sales Support Manager at Biogenuix Medsystems Pvt. Ltd., New Delhi,India.The emergence of multidrug-resistant strains of Mycobacterium tub.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing Aug 2011, 2011
ISBN 10: 3844387536 ISBN 13: 9783844387537
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 49,00
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The emergence of multidrug-resistant strains of Mycobacterium tuberculosis (Mtb) has intensified efforts to discover novel drugs for tuberculosis (TB) treatment. Targeting the persistent state of Mtb, a condition in which Mtb is resistant to conventional drug therapies, is of particular interest. Persistent bacterial population relies on metabolic pathways that become active in low nutrient environment like glyoxylate shunt. Since the glyoxylate shunt enzymes are not present in mammals, they make attractive drug targets. This study is focused on malate synthase (MS), one of the enzymes in the glyoxylate shunt.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 68 pp. Englisch.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2011
ISBN 10: 3844387536 ISBN 13: 9783844387537
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 49,00
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The emergence of multidrug-resistant strains of Mycobacterium tuberculosis (Mtb) has intensified efforts to discover novel drugs for tuberculosis (TB) treatment. Targeting the persistent state of Mtb, a condition in which Mtb is resistant to conventional drug therapies, is of particular interest. Persistent bacterial population relies on metabolic pathways that become active in low nutrient environment like glyoxylate shunt. Since the glyoxylate shunt enzymes are not present in mammals, they make attractive drug targets. This study is focused on malate synthase (MS), one of the enzymes in the glyoxylate shunt.